Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Investigation of Therapies for Down Syndrome Regression Disorder

NCT05662228 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05662228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05662228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Investigation of Therapies for Down Syndrome Regression Disorder
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
June 29, 2023
Completion date
May 28, 2026
Enrollment
66 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, regression